235 related articles for article (PubMed ID: 21159555)
1. AT2 receptor signaling and sympathetic regulation.
Gao L; Zucker IH
Curr Opin Pharmacol; 2011 Apr; 11(2):124-30. PubMed ID: 21159555
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous inflammation differentially regulates the expression and function of Angiotensin-II types 1 and 2 receptors in rat primary sensory neurons.
Benitez SG; Seltzer AM; Messina DN; Foscolo MR; Patterson SI; Acosta CG
J Neurochem; 2020 Mar; 152(6):675-696. PubMed ID: 31386177
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury.
Li J; Culman J; Hörtnagl H; Zhao Y; Gerova N; Timm M; Blume A; Zimmermann M; Seidel K; Dirnagl U; Unger T
FASEB J; 2005 Apr; 19(6):617-9. PubMed ID: 15665034
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II type 1 and type 2 receptor-induced cell signaling.
Akazawa H; Yano M; Yabumoto C; Kudo-Sakamoto Y; Komuro I
Curr Pharm Des; 2013; 19(17):2988-95. PubMed ID: 23176210
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin type 2 receptor in hypertensive cardiovascular disease.
Savoia C; D'Agostino M; Lauri F; Volpe M
Curr Opin Nephrol Hypertens; 2011 Mar; 20(2):125-32. PubMed ID: 21245762
[TBL] [Abstract][Full Text] [Related]
7. Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression.
Tadevosyan A; Maguy A; Villeneuve LR; Babin J; Bonnefoy A; Allen BG; Nattel S
J Biol Chem; 2010 Jul; 285(29):22338-49. PubMed ID: 20463030
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin AT1/AT2 receptors: regulation, signalling and function.
Kaschina E; Unger T
Blood Press; 2003; 12(2):70-88. PubMed ID: 12797627
[TBL] [Abstract][Full Text] [Related]
9. [Angiotensin II type 1 and type 2 receptor].
Akazawa H; Komuro I
Nihon Rinsho; 2009 Apr; 67(4):687-94. PubMed ID: 19348229
[TBL] [Abstract][Full Text] [Related]
10. Developmental changes in AT1 and AT2 receptor-protein expression in rats.
Yu L; Zheng M; Wang W; Rozanski GJ; Zucker IH; Gao L
J Renin Angiotensin Aldosterone Syst; 2010 Dec; 11(4):214-21. PubMed ID: 20807798
[TBL] [Abstract][Full Text] [Related]
11. Hypotensive and sympathoinhibitory responses to selective central AT2 receptor stimulation in spontaneously hypertensive rats.
Brouwers S; Smolders I; Wainford RD; Dupont AG
Clin Sci (Lond); 2015 Jul; 129(1):81-92. PubMed ID: 25655919
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II reduces mitochondrial content in skeletal muscle and affects glycemic control.
Mitsuishi M; Miyashita K; Muraki A; Itoh H
Diabetes; 2009 Mar; 58(3):710-7. PubMed ID: 19074984
[TBL] [Abstract][Full Text] [Related]
13. The Renin-Angiotensin System in Hypertension, a Constantly Renewing Classic: Focus on the Angiotensin AT
Assersen KB; Sumners C; Steckelings UM
Can J Cardiol; 2020 May; 36(5):683-693. PubMed ID: 32389341
[TBL] [Abstract][Full Text] [Related]
14. Centrally Mediated Cardiovascular Actions of the Angiotensin II Type 2 Receptor.
Steckelings UM; Kloet A; Sumners C
Trends Endocrinol Metab; 2017 Sep; 28(9):684-693. PubMed ID: 28733135
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of ligand-induced activation of angiotensin II type 1 receptor signaling by the type 2 receptor via protein kinase C.
Inuzuka T; Fujioka Y; Tsuda M; Fujioka M; Satoh AO; Horiuchi K; Nishide S; Nanbo A; Tanaka S; Ohba Y
Sci Rep; 2016 Feb; 6():21613. PubMed ID: 26857745
[TBL] [Abstract][Full Text] [Related]
16. Recent Research Advances in Renin-Angiotensin-Aldosterone System Receptors.
Azushima K; Morisawa N; Tamura K; Nishiyama A
Curr Hypertens Rep; 2020 Feb; 22(3):22. PubMed ID: 32114685
[TBL] [Abstract][Full Text] [Related]
17. Reversal of Aortic Enlargement Induced by Increased Biomechanical Forces Requires AT1R Inhibition in Conjunction With AT2R Activation.
Zhou Z; Peters AM; Wang S; Janda A; Chen J; Zhou P; Arthur E; Kwartler CS; Milewicz DM
Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):459-466. PubMed ID: 30602301
[TBL] [Abstract][Full Text] [Related]
18. AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis.
Chow BSM; Kocan M; Shen M; Wang Y; Han L; Chew JY; Wang C; Bosnyak S; Mirabito-Colafella KM; Barsha G; Wigg B; Johnstone EKM; Hossain MA; Pfleger KDG; Denton KM; Widdop RE; Summers RJ; Bathgate RAD; Hewitson TD; Samuel CS
J Am Soc Nephrol; 2019 Nov; 30(11):2191-2207. PubMed ID: 31511361
[TBL] [Abstract][Full Text] [Related]
19. Prevention of cardiac hypertrophy by angiotensin II type-2 receptor gene transfer.
Metcalfe BL; Huentelman MJ; Parilak LD; Taylor DG; Katovich MJ; Knot HJ; Sumners C; Raizada MK
Hypertension; 2004 Jun; 43(6):1233-8. PubMed ID: 15166182
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin receptor blocker selectivity at the AT1- and AT2-receptors: conceptual and clinical effects.
Unger T; Sandmann S
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S6-9. PubMed ID: 17199211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
